Curiteva于2026年1月推出了新的脊椎植入系统,标志着脊椎外科手术前科创新迈出了一大步。 Curiteva launched its new spinal implant system in January 2026, marking a major step in anterior spine surgery innovation.

位于Huntsville的一家医疗技术公司Curiteva于2026年1月9日宣布首次临床使用其Inspire独立ALIF系统, Curiteva, a Huntsville-based medical tech company, announced the first clinical use of its Inspire Standalone ALIF System on January 9, 2026, marking a key step in its anterior spinal surgery launch. 该装置是设计用于前脑膜间聚变的,装有专用的PEEEK植入器,带有生物活性纳米表面,以促进骨骼生长,并辅以经同行审查的研究。 The device, designed for anterior lumbar interbody fusion, features a proprietary PEEK implant with a bioactive nano-surface to promote bone growth, backed by a peer-reviewed study. 它补充了Curiteva现有的宫颈和后脊柱供品,形成了360度脊椎溶液。 It complements Curiteva’s existing cervical and posterior lumbar offerings, forming a 360-degree spinal solution. 该公司的首席医官Randy Dryer博士进行了第一个植入手术,他引用了骨骼融合的视觉确认。 Dr. Randy Dryer, the company’s Chief Medical Officer, performed the first implant, citing visual confirmation of bone integration. 该系统处于阿尔法发射阶段,计划于2026年晚些时候全面商业推出。 The system is in alpha launch, with a full commercial rollout planned for later in 2026. 该公司强调通过3D打印的3D型蒸气式PEEK植入器进行创新,以加强愈合和病人的结果。 The company emphasizes innovation through 3D-printed trabecular PEEK implants to enhance healing and patient outcomes.